Infinite Solutions in Antibody Innovation.
Next-gen antibody discovery: The scalable, lightning-fast new/era/mabs platform for innovative diagnostics and therapeutics across murine, human, and camelid sources.
Next-gen antibody discovery: The scalable, lightning-fast new/era/mabs platform for innovative diagnostics and therapeutics across murine, human, and camelid sources.
new/era/mabs offers comprehensive support from target analysis to antibody manufacturing, catering to diverse needs in research, diagnostics, and therapy. Our unique immortal cell pools provide infinite screening options for immediate antibody solutions.
new/era/mabs is enhancing the global response to pandemics by using its existing scalable platform for the rapid discovery of specific antibodies. Our technology enables the creation of immortal cell pools that target specific antigens. These pools can be screened infinitely to identify precise antibodies for use in research, diagnostics, and treatment. This capability is a crucial asset to enhance preparedness for future pandemic threats.
Our Service
We handle every step of the process, from target analysis to purification, ensuring personalized and efficient support for your research.
From mouse to camelid and human antibodies, we provide tailored sets specific to your target, ensuring comprehensive coverage and efficacy.
Use the opportunity to create antigen-specific and immature cell pools for infinite screening options with selma.
Need enzyme/tag modifications or engineered formats? We've got you covered. Whether it's exchanging Fc regions, creating bispecific antibodies, or developing chimeric formats, we excel in customizing antibodies to meet your exact specifications.
Our team specializes in developing customized antibody-based assay formats and flow cytometry workflows, empowering you with precise and reliable tools for your research endeavors.
new/era/mabs offers a variety of catalogue antibodies and antigen-specific immortal cell pools. Customized screening options for mouse, human and camelid antibodies are available upon request. We provide comprehensive antibody and recombinant protein manufacturing capabilities, including small and large-scale options, as well as the generation of overexpressing cell lines.
Creating innovative antibodies with new/era/mabs was a snap. Within a few short weeks, we received high affinity purified potent antibodies, allowing our research on auto-immune encephalitis to move forward quickly. Highly recommended!
I'm very impressed by the technology, Katja and her team developed to select antibody producing cells. I strongly advocate her services.
Katja and I collaborate in a SARS-CoV2 project where new/era/mabs provides specific camelid antibodies for our test device. I´m very proud to have her on board. Using the antibody specific support from her team will essentially foster the successful implementation of our device.
The cooperation with Katja and her team is incredible and helps us to develop our products much faster and with higher efficacy. We are very convinced of the quality of their work and the reliability and passion to solve any custom-related issues.
